Quantitation of antibodies to the spike protein of severe acute respiratory syndrome
coronavirus 2 (SARS‐CoV‐2) was performed for the detection of adaptive immune response …

ABSTRACT SARS-CoV-2, the causative agent of the COVID-19 pandemic, continues to
influence health, economy, and stability worldwide. Diagnostic testing for SARS-CoV-2 is …

Laboratory testing has been a key tool in managing the SARS-CoV-2 global pandemic.
While rapid antigen and PCR testing has proven useful for diagnosing acute SARS-CoV-2 …

Serological tests are beneficial for recognizing the immune response against severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2). To identify protective immunity …

Data regarding response to SARS-CoV-2 immunization in pediatric patients with
predominantly antibody deficiency (PAD) is limited. We evaluated SARS-CoV-2 …

Continuous surveillance of COVID-19 diffusion remains crucial to control its diffusion and to
anticipate infection waves. Detecting viral RNA load in wastewater samples has been …

We investigated how differences in age, sex, or vaccine type can affect humoral and cellular
immune responses after vaccination with vector (ChAdOx1 nCoV-19), mix-and-match (first …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in
patients with predominant antibody deficiency (PAD) is associated with high morbidity, yet …

Context.—Moderna (mRNA-1272) and Pfizer (BNT162b2) SARS-CoV-2 vaccines
demonstrate favorable safety and efficacy profiles, but direct comparison data are lacking …

Comprehensive assessment of SARS-CoV-2 antibodies against antigenic epitopes and
cross-neutralization on variants is essential to monitor after infection or vaccination. From 32 …